Literature DB >> 23323905

Antiretroviral therapy in early HIV infection.

Bruce D Walker, Martin S Hirsch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23323905     DOI： 10.1056/NEJMe1213734

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

Review 1.  Antiretroviral therapy: when to start.

Authors:  Christopher J Sellers; David A Wohl
Journal:  Infect Dis Clin North Am       Date:  2014-09       Impact factor: 5.982

2.  Early treatment and HIV-1 reservoirs: a stitch in time?

Authors:  Timothy J Henrich; Rajesh T Gandhi
Journal:  J Infect Dis       Date:  2013-07-12       Impact factor: 5.226

Review 3.  Clinical development of candidate HIV vaccines: different problems for different vaccines.

Authors:  Stuart Z Shapiro
Journal:  AIDS Res Hum Retroviruses       Date:  2013-11-22       Impact factor: 2.205

Review 4.  HIV therapeutic vaccines: moving towards a functional cure.

Authors:  Geetha H Mylvaganam; Guido Silvestri; Rama Rao Amara
Journal:  Curr Opin Immunol       Date:  2015-05-18       Impact factor: 7.486

Review 5.  Toward an endgame: finding and engaging people unaware of their HIV-1 infection in treatment and prevention.

Authors:  David N Burns; Victor DeGruttola; Christopher D Pilcher; Mirjam Kretzschmar; Christopher M Gordon; Elizabeth H Flanagan; Christopher Duncombe; Myron S Cohen
Journal:  AIDS Res Hum Retroviruses       Date:  2014-02-11       Impact factor: 2.205

Review 6.  The role of Pannexin-1 channels and extracellular ATP in the pathogenesis of the human immunodeficiency virus.

Authors:  Daniela D'Amico; Silvana Valdebenito; Eliseo A Eugenin
Journal:  Purinergic Signal       Date:  2021-09-20       Impact factor: 3.765

Review 7.  Monocyte/macrophages and their role in HIV neuropathogenesis.

Authors:  Tricia H Burdo; Andrew Lackner; Kenneth C Williams
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

8.  Implementation of an Immediate HIV Treatment Initiation Program in a Public/Academic Medical Center in the U.S. South: The Miami Test and Treat Rapid Response Program.

Authors:  Allan E Rodriguez; Andrew J Wawrzyniak; Hansel E Tookes; Marcia G Vidal; Manasi Soni; Rita Nwanyanwu; David Goldberg; Rachel Freeman; Kira Villamizar; Maria L Alcaide; Michael A Kolber
Journal:  AIDS Behav       Date:  2019-10

9.  Dendritic cell targeted HIV-1 gag protein vaccine provides help to a recombinant Newcastle disease virus vectored vaccine including mobilization of protective CD8+ T cells.

Authors:  Loveline N Ngu; Nadesh N Nji; Georgia Ambada; Apeh A Ngoh; Ghislain D Njambe Priso; Jules C Tchadji; Abel Lissom; Suzanne H Magagoum; Carol N Sake; Thibau F Tchouangueu; George O Chukwuma; Arinze S Okoli; Bertrand Sagnia; Rebecca Chukwuanukwu; Denis M Tebit; Charles O Esimone; Alain B Waffo; Chae G Park; Klaus Überla; Godwin W Nchinda
Journal:  Immun Inflamm Dis       Date:  2017-12-04

10.  Determinants of antiretroviral therapy coverage in Sub-Saharan Africa.

Authors:  Fumitaka Furuoka; Mohammad Zahirul Hoque
Journal:  PeerJ       Date:  2015-12-08       Impact factor: 2.984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.